DK1154766T3 - Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B - Google Patents

Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B

Info

Publication number: DK1154766T3
Authority: DK; Denmark
Prior art keywords: diseases; kappa; activation; drugs; inhibiting
Prior art date: 1999-02-24

Application number

DK00904922T

Other languages

English (en)

Inventor

Gerd Geisslinger

Kay Brune

Original Assignee

Paz Arzneimittelentwicklung

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-24

Filing date

2000-01-17

Publication date

2007-05-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7898653&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1154766(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-01-17 Application filed by Paz Arzneimittelentwicklung filed Critical Paz Arzneimittelentwicklung

2007-05-14 Application granted granted Critical

2007-05-14 Publication of DK1154766T3 publication Critical patent/DK1154766T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK00904922T 1999-02-24 2000-01-17 Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B DK1154766T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19907895A DE19907895A1 (de)	1999-02-24	1999-02-24	Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen bei Mensch und Tier, welche durch die Hemmung der Aktivierung von NF-kB therapeutisch beeinflußt werden können
PCT/EP2000/000323 WO2000050019A2 (de)	1999-02-24	2000-01-17	VERWENDUNG VON R-ARYLPROPIONSÄUREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ZUR BEHANDLUNG VON ERKRANKUNGEN BEI MENSCH UND TIER, WELCHE DURCH DIE HEMMUNG DER AKTIVIERUNG VON NF-λB THERAPEUTISCH BEEINFLUSST WERDEN KÖNNEN

Publications (1)

Publication Number	Publication Date
DK1154766T3 true DK1154766T3 (da)	2007-05-14

Family

ID=7898653

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00904922T DK1154766T3 (da)	1999-02-24	2000-01-17	Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B

Country Status (11)

Country	Link
EP (1)	EP1154766B1 (da)
JP (1)	JP2002537325A (da)
AT (1)	ATE350027T1 (da)
CA (1)	CA2362888C (da)
CY (1)	CY1108004T1 (da)
DE (2)	DE19907895A1 (da)
DK (1)	DK1154766T3 (da)
ES (1)	ES2280196T3 (da)
PT (1)	PT1154766E (da)
RU (1)	RU2250103C2 (da)
WO (1)	WO2000050019A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10047319A1 (de) *	2000-09-25	2002-04-18	Paz Arzneimittelentwicklung	Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen, welche durch die Hemmung der Aktivierung des nukleären Transkriptionsfaktors AP-1 therapeutisch beeinflußt werden können
ITMI20012434A1 (it) *	2001-11-20	2003-05-20	Dompe Spa	Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
ITMI20030312A1 (it) *	2003-02-21	2004-08-22	Chiesi Farma Spa	Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer.
KR20060040676A (ko) *	2003-07-11	2006-05-10	미리어드 제네틱스, 인크.	알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
RU2532027C2 (ru)	2009-07-24	2014-10-27	Мика Фарма Гезельшафт Фюр Ди Энтвиклюнг Унд Фермарктунг Фармацойтишер Продукте Мбх	Жидкие композиции, способные к пенообразованию и включающие активные средства, и способы их получения и разработки
GB2485169A (en) *	2010-11-03	2012-05-09	Univ Jw Goethe Frankfurt Main	(R)-flurbiprofen for use in the treatment of multiple sclerosis
EP2468270A1 (en)	2010-12-21	2012-06-27	GALENpharma GmbH	(R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
RU2457840C1 (ru) *	2011-03-09	2012-08-10	Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации	Средство, воздействующее на активность некоторых ядерных факторов транскрипции
WO2014007780A1 (en)	2012-07-06	2014-01-09	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Orally-disintegrating formulations of dexketoprofen
WO2014007779A1 (en)	2012-07-06	2014-01-09	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Orally-disintegrating formulations of dexketoprofen
RU2675693C1 (ru) *	2017-11-16	2018-12-24	Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ")	Способ ингибирования нуклеарного фактора каппа В с использованием 5-гидроксиникотината калия в культуре клеток

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4028906A1 (de) *	1990-09-12	1992-03-19	Paz Arzneimittelentwicklung	Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
JP3265680B2 (ja) *	1992-03-12	2002-03-11	大正製薬株式会社	経口製剤用組成物
DE4319438C1 (de) *	1993-06-11	1994-06-01	Gerd Dr Dr Geislinger	Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
US6160018A (en) *	1995-03-13	2000-12-12	Loma Linda University Medical Center	Prophylactic composition and method for alzheimer's Disease
DE19716713A1 (de) *	1997-04-21	1998-10-22	Paz Arzneimittelentwicklung	Arzneimittel, enthaltend Ibuprofenthioester als Hemmer der Nf-kappaB abhängigen Bildung von Mediatoren von Entzündung und Schmerz
EP1143958B8 (en) *	1998-09-03	2007-05-23	Loma Linda University Medical Center	Pharmaceutical composition and use of rnsaid for treating inflammation

1999
- 1999-02-24 DE DE19907895A patent/DE19907895A1/de not_active Ceased
2000
- 2000-01-17 AT AT00904922T patent/ATE350027T1/de not_active IP Right Cessation
- 2000-01-17 RU RU2001126056/15A patent/RU2250103C2/ru not_active IP Right Cessation
- 2000-01-17 WO PCT/EP2000/000323 patent/WO2000050019A2/de active IP Right Grant
- 2000-01-17 CA CA002362888A patent/CA2362888C/en not_active Expired - Fee Related
- 2000-01-17 EP EP00904922A patent/EP1154766B1/de not_active Expired - Lifetime
- 2000-01-17 JP JP2000600631A patent/JP2002537325A/ja active Pending
- 2000-01-17 PT PT00904922T patent/PT1154766E/pt unknown
- 2000-01-17 DE DE50013934T patent/DE50013934D1/de not_active Expired - Lifetime
- 2000-01-17 DK DK00904922T patent/DK1154766T3/da active
- 2000-01-17 ES ES00904922T patent/ES2280196T3/es not_active Expired - Lifetime
2007
- 2007-03-13 CY CY20071100348T patent/CY1108004T1/el unknown

Also Published As

Publication number	Publication date
WO2000050019A2 (de)	2000-08-31
DE50013934D1 (de)	2007-02-15
CA2362888C (en)	2009-02-24
ES2280196T3 (es)	2007-09-16
EP1154766A2 (de)	2001-11-21
PT1154766E (pt)	2007-03-30
CY1108004T1 (el)	2013-09-04
ATE350027T1 (de)	2007-01-15
RU2250103C2 (ru)	2005-04-20
DE19907895A1 (de)	2000-11-16
JP2002537325A (ja)	2002-11-05
WO2000050019A3 (de)	2000-12-14
EP1154766B1 (de)	2007-01-03
CA2362888A1 (en)	2000-08-31

Publication	Publication Date	Title
CY1108004T1 (el)	2013-09-04	Χρηση r-αρυλοπροπιονικων οξεων για την παραγωγη φαρμακων για την αντιμετωπιση παθησεων σε ανθρωπους και ζωα, οι οποιες μπορουν να επηρεαστουν θepαπευτικα μεσω της αναστολης της ενepγοποιησης του nf-kb
ATE472325T1 (de)	2010-07-15	Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60225556D1 (de)	2008-04-24	Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
DE60038162D1 (de)	2008-04-10	Celecoxib in festkörperform mit erhöhter bioverfügbarkeit
DE69940131D1 (de)	2009-01-29	Mittel zur Behandlung von Erkrankungen der Speiseröhre
ATE429922T1 (de)	2009-05-15	Topische gel-abgabesysteme zur behandlung von hauterkrankungen
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
ATE450269T1 (de)	2009-12-15	Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
NO20014046L (no)	2001-08-20	Gabapentinderivater for forhindring og behandling av visceral smerte
DE69725879D1 (de)	2003-12-04	VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
DE50211137D1 (de)	2007-12-13	Seitenkettenhalogenierte aminodicarbonsaurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
BR9917495A (pt)	2002-06-11	Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
DE60026491D1 (de)	2006-05-04	Melagatran zur behandlung von entzündungen
PT1206444E (pt)	2004-04-30	Compostos que inibem a actividade da triptase
ATE357912T1 (de)	2007-04-15	Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
NO20006506D0 (no)	2000-12-20	Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
ATE330596T1 (de)	2006-07-15	Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
NO952601L (no)	1996-01-02	Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
WO2000061125A3 (fr)	2001-04-19	L'osanetant dans le traitement des troubles de l'humeur
NO20026148D0 (no)	2002-12-20	Medisiner for forhindring og behandling av neurodegenerative sykdommer
DE60219680D1 (de)	2007-05-31	Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit
PT1183046E (pt)	2003-12-31	Derivado de aminotetralina para a terapia de doencas cardiovasculares
ATE359270T1 (de)	2007-05-15	Phenyl-piperidin-4-yliden-methyl-benzamidderiva e zur behandlung von schmerz oder magen-darm- erkrankungen
PT865278E (pt)	2002-10-31	Utilizacao de 1-hidroxi-2-piridonas para o tratamento de doencas terapeuticamente dificeis de mucosidade da pele